Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1996;93(3):193-8.
doi: 10.1007/BF02569059.

Effect of topical cyclosporin A on Thygeson's superficial punctate keratitis

Affiliations

Effect of topical cyclosporin A on Thygeson's superficial punctate keratitis

J M Del Castillo et al. Doc Ophthalmol. 1996.

Abstract

Thygeson's superficial punctate keratitis (Thygeson's SPK) is a distinct clinical entity, characterized by round conglomerates of discrete, granular, white-gray, fine intraepithelial dots without conjunctival involvement. The only effective treatment with regard to relieving symptoms and diminishing lesions has been topical corticosteroids, but their prolonged use can be associated with severe side-effects. The purpose of this study is to present the long-term results of the use of 2% topical cyclosporin A in olive oil in Thygeson's SPK. Eight patients diagnosed as having Thygeson's SPK were included. All the patients were treated with 2% cyclosporin dissolved in olive oil four times a day for three months, and two times a day for one month before withdrawing therapy. The follow-up period ranged from twelve to twenty-five months. The number of corneal lesions varied between 5 and 15 before treatment. After cyclosporin treatment, no corneal lesion was observed and the cornea remained clear after the follow-up period. In conclusion, 2% cyclosporin in olive oil is a safe alternative to corticosteroids in the treatment of Thygeson's SPK, and resulted in satisfactory control of the condition.

PubMed Disclaimer

References

    1. Am J Ophthalmol. 1979 Aug;88(2):186-9 - PubMed
    1. Ophthalmology. 1981 Jan;88(1):75-7 - PubMed
    1. Arch Ophthalmol. 1974 Jan;91(1):8-10 - PubMed
    1. Trans Am Ophthalmol Soc. 1981;79:486-516 - PubMed
    1. Ophthalmology. 1984 Oct;91(10):1188-92 - PubMed

MeSH terms

LinkOut - more resources